UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Ramucirumab plus docetaxel versus placebo plus docetaxel for second-line treatment of stage IV non-small-cell lung cancer after disease progression on platinum-based therapy (REVEL): a multicentre, double-blind, randomised phase 3 trial

The Lancet (British edition), 2014-08, Vol.384 (9944), p.665-673

2014

Volltextzugriff (PDF)

Randomized Phase II Trial of Onartuzumab in Combination With Erlotinib in Patients With Advanced Non–Small-Cell Lung Cancer

Journal of clinical oncology, 2013-11, Vol.31 (32), p.4105-4114

2013

Volltextzugriff (PDF)

Current status of molecular diagnostics for lung cancer

Exploration of targeted anti-tumor therapy, 2024-01, Vol.5 (3), p.742-765

2024

Volltextzugriff (PDF)

Inflammatory and autoimmune predictive markers of response to anti‑PD‑1/PD‑L1 therapy in NSCLC and melanoma

Experimental and therapeutic medicine, 2022-09, Vol.24 (3), Article 557

2022

Volltextzugriff (PDF)

Regulation of Apolipoprotein A-I Gene Expression in Human Macrophages by Oxidized Low-Density Lipoprotein

Biochemistry (Moscow), 2021-10, Vol.86 (10), p.1201-1213

2021

Volltextzugriff (PDF)

Complexes of Plasmid DNA with Basic Domain 47-57 of the HIV-1 Tat Protein Are Transferred to Mammalian Cells by Endocytosis-mediated Pathways

The Journal of biological chemistry, 2003-10, Vol.278 (43), p.42625-42636

2003

Volltextzugriff (PDF)

Predictive markers of response to immune checkpoint inhibitor rechallenge in metastatic non-small cell lung cancer

Exploration of targeted anti-tumor therapy, 2024-01, Vol.5 (6), p.1271-1288

2024

Volltextzugriff (PDF)

Response to trametinib, hydroxychloroquine, and bevacizumab in a young woman with NRAS -mutated metastatic intrahepatic cholangiocarcinoma: a case report

Exploration of targeted anti-tumor therapy, 2024-01, Vol.5 (3), p.780-788

2024

Volltextzugriff (PDF)

Efficacy of lorlatinib in lung carcinomas carrying distinct ALK translocation variants: The results of a single-center study

Translational oncology, 2021-08, Vol.14 (8), p.101121-101121, Article 101121

2021

Volltextzugriff (PDF)

Rapid Improvement of the Performance Status and Reduction of the Tumor Size in KRAS-Mutated Colorectal Cancer Patient Receiving Binimetinib, Hydroxychloroquine, and Bevacizumab

Case reports in oncology, 2020-08, Vol.13 (2), p.985-989

2020

Volltextzugriff (PDF)

Capmatinib in MET Exon 14–Mutated or MET-Amplified Non–Small-Cell Lung Cancer

The New England journal of medicine, 2020-09, Vol.383 (10), p.944-957

2020

Volltextzugriff (PDF)

Adjuvant Erlotinib Versus Placebo in Patients With Stage IB-IIIA Non-Small-Cell Lung Cancer (RADIANT): A Randomized, Double-Blind, Phase III Trial

Journal of clinical oncology, 2015-12, Vol.33 (34), p.4007-4014

2015

Volltextzugriff (PDF)

Detection of EGFR mutations and EML4‐ALK rearrangements in lung adenocarcinomas using archived cytological slides

Cancer cytopathology, 2013-07, Vol.121 (7), p.370-376

2013

Volltextzugriff (PDF)

A global phase II randomized trial comparing oral taxane ModraDoc006/r to intravenous docetaxel in metastatic castration resistant prostate cancer

European journal of cancer (1990), 2024-05, Vol.202, p.114007-114007, Article 114007

2024

Volltextzugriff (PDF)

Treating non-small cell lung cancer with selumetinib: an up-to-date drug evaluation

Expert opinion on pharmacotherapy, 2020-11, Vol.21 (16), p.1943-1953

2020

Volltextzugriff (PDF)

Insulin Downregulates the Expression of ATP-binding Cassette Transporter A-I in Human Hepatoma Cell Line HepG2 in a FOXO1 and LXR Dependent Manner

Cell biochemistry and biophysics, 2023-03, Vol.81 (1), p.151-160

2023

Volltextzugriff (PDF)

Differentiation of human macrophages with anaphylatoxin C3a impairs alternative M2 polarization and decreases lipopolysaccharide‐induced cytokine secretion

Immunology and cell biology, 2022-03, Vol.100 (3), p.186-204

2022

Volltextzugriff (PDF)

Correction to: Insulin Downregulates the Expression of ATP-binding Cassette Transporter A-I in Human Hepatoma Cell Line HepG2 in a FOXO1 and LXR Dependent Manner

Cell biochemistry and biophysics, 2023-03, Vol.81 (1), p.161-161

2023

Volltextzugriff (PDF)

Adiponectin Stimulates Apolipoprotein A-1 Gene Expression in HepG2 Cells via AMPK, PPARα, and LXRs Signaling Mechanisms

Biochemistry (Moscow), 2022-11, Vol.87 (11), p.1252-1259

2022

Volltextzugriff (PDF)

Tumor necrosis factor α stimulates endogenous apolipoprotein A-I expression and secretion by human monocytes and macrophages: role of MAP-kinases, NF-κB, and nuclear receptors PPARα and LXRs

Molecular and cellular biochemistry, 2018-11, Vol.448 (1-2), p.211-223

2018

Volltextzugriff (PDF)

Variability in lung cancer response to ALK inhibitors cannot be explained by the diversity of ALK fusion variants

Biochimie, 2018-11, Vol.154, p.19-24

2018

Volltextzugriff (PDF)

Double-Blind, Placebo-Controlled, Randomized Phase 2 Study of the Proapoptotic Agent AT-101 Plus Docetaxel, in Second-Line Non-small Cell Lung Cancer

Journal of thoracic oncology, 2011-04, Vol.6 (4), p.781-785

2011

Volltextzugriff (PDF)

Assessment of the impact of the use of durvalumab for the treatment of advanced small cell lung cancer on the achievement of the target "reduction in mortality from neoplasms"

Sovremennaia onkologiia : zhurnal kafedry onkologii RMAPO dlia nepreryvnogo poslediplomnogo obrazovaniia, 2022-04, Vol.24 (1), p.30-40

2022

Volltextzugriff (PDF)

Insulin‐Mediated Downregulation of Apolipoprotein A‐I Gene in Human Hepatoma Cell Line HepG2: The Role of Interaction Between FOXO1 and LXRβ Transcription Factors

Journal of cellular biochemistry, 2017-02, Vol.118 (2), p.382-396

2017

Volltextzugriff (PDF)

Phase III Trial Comparing Paclitaxel Poliglumex (CT-2103, PPX) in Combination with Carboplatin Versus Standard Paclitaxel and Carboplatin in the Treatment of PS 2 Patients with Chemotherapy-Naïve Advanced Non-small Cell Lung Cancer

Journal of thoracic oncology, 2008-06, Vol.3 (6), p.623-630

2008

Volltextzugriff (PDF)

1 – 25 von 316

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(259)
Mit Volltextzugriff
(247)

Publikationsform

Sprache

Englisch
(312)
Russisch
(13)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(168)
Life Sciences & Biomedicine
(95)
Physical Sciences
(65)
Humans
(60)
Chemistry
(38)
Technology
(38)
Oncology
(32)
Female
(29)
Male
(29)
Physics
(28)
Middle Aged
(25)
Aged
(24)
Biochemistry & Molecular Biology
(24)
Lung Neoplasms - Drug Therapy
(23)
Adult
(22)
Physics, Applied
(21)
Carcinoma, Non-Small-Cell Lung - Drug Therapy
(19)
Materials Science
(17)
Lung Neoplasms - Pathology
(16)
Fmri
(15)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(6)

Menü

Weitere Dienste

Einstellungen

Ramucirumab plus docetaxel versus placebo plus docetaxel for second-line treatment of stage IV non-small-cell lung cancer after disease progression on platinum-based therapy (REVEL): a multicentre, double-blind, randomised phase 3 trial

Randomized Phase II Trial of Onartuzumab in Combination With Erlotinib in Patients With Advanced Non–Small-Cell Lung Cancer

Current status of molecular diagnostics for lung cancer

Inflammatory and autoimmune predictive markers of response to anti‑PD‑1/PD‑L1 therapy in NSCLC and melanoma

Regulation of Apolipoprotein A-I Gene Expression in Human Macrophages by Oxidized Low-Density Lipoprotein

Complexes of Plasmid DNA with Basic Domain 47-57 of the HIV-1 Tat Protein Are Transferred to Mammalian Cells by Endocytosis-mediated Pathways

Predictive markers of response to immune checkpoint inhibitor rechallenge in metastatic non-small cell lung cancer

Response to trametinib, hydroxychloroquine, and bevacizumab in a young woman with NRAS -mutated metastatic intrahepatic cholangiocarcinoma: a case report

Efficacy of lorlatinib in lung carcinomas carrying distinct ALK translocation variants: The results of a single-center study

Rapid Improvement of the Performance Status and Reduction of the Tumor Size in KRAS-Mutated Colorectal Cancer Patient Receiving Binimetinib, Hydroxychloroquine, and Bevacizumab

Capmatinib in MET Exon 14–Mutated or MET-Amplified Non–Small-Cell Lung Cancer

Adjuvant Erlotinib Versus Placebo in Patients With Stage IB-IIIA Non-Small-Cell Lung Cancer (RADIANT): A Randomized, Double-Blind, Phase III Trial

Detection of EGFR mutations and EML4‐ALK rearrangements in lung adenocarcinomas using archived cytological slides

A global phase II randomized trial comparing oral taxane ModraDoc006/r to intravenous docetaxel in metastatic castration resistant prostate cancer

Treating non-small cell lung cancer with selumetinib: an up-to-date drug evaluation

Insulin Downregulates the Expression of ATP-binding Cassette Transporter A-I in Human Hepatoma Cell Line HepG2 in a FOXO1 and LXR Dependent Manner

Differentiation of human macrophages with anaphylatoxin C3a impairs alternative M2 polarization and decreases lipopolysaccharide‐induced cytokine secretion

Correction to: Insulin Downregulates the Expression of ATP-binding Cassette Transporter A-I in Human Hepatoma Cell Line HepG2 in a FOXO1 and LXR Dependent Manner

Adiponectin Stimulates Apolipoprotein A-1 Gene Expression in HepG2 Cells via AMPK, PPARα, and LXRs Signaling Mechanisms

Tumor necrosis factor α stimulates endogenous apolipoprotein A-I expression and secretion by human monocytes and macrophages: role of MAP-kinases, NF-κB, and nuclear receptors PPARα and LXRs

Variability in lung cancer response to ALK inhibitors cannot be explained by the diversity of ALK fusion variants

Double-Blind, Placebo-Controlled, Randomized Phase 2 Study of the Proapoptotic Agent AT-101 Plus Docetaxel, in Second-Line Non-small Cell Lung Cancer

Assessment of the impact of the use of durvalumab for the treatment of advanced small cell lung cancer on the achievement of the target "reduction in mortality from neoplasms"

Insulin‐Mediated Downregulation of Apolipoprotein A‐I Gene in Human Hepatoma Cell Line HepG2: The Role of Interaction Between FOXO1 and LXRβ Transcription Factors

Phase III Trial Comparing Paclitaxel Poliglumex (CT-2103, PPX) in Combination with Carboplatin Versus Standard Paclitaxel and Carboplatin in the Treatment of PS 2 Patients with Chemotherapy-Naïve Advanced Non-small Cell Lung Cancer

Suchergebnisse filtern